您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > 重组MEK1/MAPKK1(N-端)蛋白
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
重组MEK1/MAPKK1(N-端)蛋白
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。

产品名称
重组丝裂原活化蛋白激酶激酶1
Recombinant MAP2K2
产品介绍
基因名:

MAP2K2


产品别名:

CFC4; MAPKK2; MEK2; MKK2; PRKMK2; MAP2K2; mitogen-activated protein kinase kinase 2; mitogen-activated protein kinase kinase 2; dual specificity mitogen-activated protein kinase kinase 2; ERK activator kinase 2; MAP kinase kinase 2; MAPK/ERK kinase 2; mitogen-activated protein kinase kinase 2, p45; MEK1/MAPKK1(N-端); 丝裂原活化蛋白激酶激酶1; 丝裂原活化蛋白激酶激酶2; 丝裂原激活蛋白激酶激酶2(MAP2K2); 磷酸化丝裂原活化蛋白激酶1; 磷酸化丝裂原活化蛋白激酶激酶1; 磷酸化丝裂原活化蛋白激酶激酶1/2; 磷酸化丝裂原活化蛋白激酶激酶2;


背景信息:
The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, mental retardation, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. [provided by RefSeq, Jul 2008].

标签:His-tag   
分类:Recombinant  
类型:Protein   
偶联物:Unconjugated
内毒素水平:按批次,参阅瓶身标签
性状:Liquid
浓度:Batch dependent (Please refer to the vial label for the specific concentration.)
纯化类型:purified
内含物:不含防腐剂
应用:Positive Control;Immunogen;SDS-PAGE;WB.
储存:2-8°C不超过一个月,-80°C不超过12个月。避免反复冻融。
注意事项:仅供实验室使用。不适用于人类或动物的任何临床,治疗或诊断用途。不适合动物或人类食用。